C Berger1, M Berger, D Anderson, S R Riddell. 1. Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. cberger@fhcrc.org
Abstract
BACKGROUND: Adoptive immunotherapy with antigen-specific effector T-cell (T(E) ) clones is often limited by poor survival of the transferred cells. We describe here a Macaca nemestrina model for studying transfer of T-cell immunity. METHODS: We derived, expanded, and genetically marked CMV-specific CD8(+) T(E) clones with surface markers expressed on B cells. T(E) cells were adoptively transferred, and toxicity, persistence, retention of introduced cell-surface markers, and phenotype of the persisting T cells were evaluated. RESULTS: CD8(+) T(E) clones were efficiently isolated from distinct memory precursors and gene-marking with CD19 or CD20 permitted in vivo tracking by quantitative PCR. CD19 was a more stable surface marker for tracking cells in vivo and was used to re-isolate cells for functional analysis. Clonally derived CD8(+) T(E) cells differentiated in vivo to phenotypically and functionally heterogeneous memory T-cell subsets. CONCLUSIONS: These studies demonstrate the utility of Macaca nemestrina for establishing principles for T-cell therapeutics applicable to humans.
BACKGROUND: Adoptive immunotherapy with antigen-specific effector T-cell (T(E) ) clones is often limited by poor survival of the transferred cells. We describe here a Macaca nemestrina model for studying transfer of T-cell immunity. METHODS: We derived, expanded, and genetically marked CMV-specific CD8(+) T(E) clones with surface markers expressed on B cells. T(E) cells were adoptively transferred, and toxicity, persistence, retention of introduced cell-surface markers, and phenotype of the persisting T cells were evaluated. RESULTS:CD8(+) T(E) clones were efficiently isolated from distinct memory precursors and gene-marking with CD19 or CD20 permitted in vivo tracking by quantitative PCR. CD19 was a more stable surface marker for tracking cells in vivo and was used to re-isolate cells for functional analysis. Clonally derived CD8(+) T(E) cells differentiated in vivo to phenotypically and functionally heterogeneous memory T-cell subsets. CONCLUSIONS: These studies demonstrate the utility of Macaca nemestrina for establishing principles for T-cell therapeutics applicable to humans.
Authors: Carolina Berger; C Anthony Blau; Meei-Li Huang; John D Iuliucci; David C Dalgarno; Joëlle Gaschet; Shelly Heimfeld; Tim Clackson; Stanley R Riddell Journal: Blood Date: 2003-10-16 Impact factor: 22.113
Authors: Karl S Peggs; Stephanie Verfuerth; Arnold Pizzey; Naeem Khan; Malcolm Guiver; Paul A Moss; Stephen Mackinnon Journal: Lancet Date: 2003-10-25 Impact factor: 79.321
Authors: Thomas J Manley; Lisa Luy; Thomas Jones; Michael Boeckh; Helen Mutimer; Stanley R Riddell Journal: Blood Date: 2004-03-23 Impact factor: 22.113
Authors: Christopher W Peterson; Patrick Younan; Patricia S Polacino; Nicholas J Maurice; Hannah W Miller; Martin Prlic; Keith R Jerome; Ann E Woolfrey; Shiu-Lok Hu; Hans-Peter Kiem Journal: J Med Primatol Date: 2013-10 Impact factor: 0.667
Authors: Carolina Berger; Daniel Sommermeyer; Michael Hudecek; Michael Berger; Ashwini Balakrishnan; Paulina J Paszkiewicz; Paula L Kosasih; Christoph Rader; Stanley R Riddell Journal: Cancer Immunol Res Date: 2014-10-29 Impact factor: 11.151
Authors: Dirk H Busch; Simon P Fräßle; Daniel Sommermeyer; Veit R Buchholz; Stanley R Riddell Journal: Semin Immunol Date: 2016-03-11 Impact factor: 11.130
Authors: Stanley R Riddell; Daniel Sommermeyer; Carolina Berger; Lingfeng Steven Liu; Ashwini Balakrishnan; Alex Salter; Michael Hudecek; David G Maloney; Cameron J Turtle Journal: Cancer J Date: 2014 Mar-Apr Impact factor: 3.360
Authors: Partow Kebriaei; Susan S Kelly; Pallavi Manuri; Bipulendu Jena; Rineka Jackson; Elizabeth Shpall; Richard Champlin; Laurence J N Cooper Journal: Front Biosci (Schol Ed) Date: 2012-01-01
Authors: Carolina Berger; Michael Berger; Brian C Beard; Hans-Peter Kiem; Theodore A Gooley; Stanley R Riddell Journal: PLoS One Date: 2013-02-13 Impact factor: 3.240